The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell Carcinoma

NCT03800953 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Tumor
Metastatic Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Avelumab

Sponsor

National Taiwan University Hospital